跳至主要内容
临床试验/JPRN-UMIN000010546
JPRN-UMIN000010546已完成2 期

Safety and efficacy of conditioning regimen with fludarabine and targeted dose intravenous busulfan for elderly patinets - Safety and efficacy of conditioning regimen with fludarabine and targeted dose intravenous busulfan for elderly patinets

Chiba University Hospital, Department of Hematology0 个研究点目标入组 25 人开始时间: 2013年4月19日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
16years-old 至 70years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patient who receieved chemotherapy within 4 weeks prior the day of transplantation. Patients who received gemtuzumab ozogamicin within 3 months prior of transplantation Patients underwent allogeneic transplantation within 1 year HCI-CI higher than 3 points Patients with active double malignancies Patinets with active infection Positivith of HIV-Ab, TPHA, HBs-AB, and HCV-Ab Uncontrolable diabetes and hypertention

研究者

发起方
Chiba University Hospital, Department of Hematology

相似试验